ALZpath Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $8.41M

  • Investors
  • 3

ALZpath General Information

Description

Provider of biotechnology and laboratory research services intended to improve the lives of those impacted by Alzheimer's disease. The company offers diagnosis, intervention, and personalized treatment to transform the disease ecosystem and test measures levels of pTau217 in the blood to diagnose in its early stages, enabling healthcare providers to improve timely and accurate detection.

Contact Information

Website
www.alzpath.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2292 Faraday Avenue
  • Carlsbad, CA 92008
  • United States
+1 (844)
Primary Industry
Other Devices and Supplies
Corporate Office
  • 2292 Faraday Avenue
  • Carlsbad, CA 92008
  • United States
+1 (844)

ALZpath Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ALZpath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 21-Jul-2026 $8.41M Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Accelerator/Incubator 21-May-2024 $1.9M Completed Generating Revenue
1. Accelerator/Incubator 19-Jul-2023 $1.9M $1.9M Completed Generating Revenue
To view ALZpath’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ALZpath Patents

ALZpath Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260110700-A1 Methods for remote blood collection, extraction and analysis of neuro biomarkers Pending 14-Jul-2023
WO-2025019332-A1 Methods for remote blood collection, extraction and analysis of neuro biomarkers Inactive 14-Jul-2023
AU-2024235526-A1 Methods of diagnosing and treating neurodegenerative disorders Pending 16-Mar-2023
EP-4680633-A1 Methods of diagnosing and treating neurodegenerative disorders Pending 16-Mar-2023
US-20260008840-A1 Methods of diagnosing and treating neurodegenerative disorders Pending 16-Mar-2023 C07K16/18
To view ALZpath’s complete patent history, request access »

ALZpath Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ALZpath Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
StartUp Health Venture Capital Minority
Alzheimers Drug Discovery Foundation Not-For-Profit Venture Capital
Stead Impact Ventures and Foundation Impact Investing Minority
To view ALZpath’s complete investors history, request access »

ALZpath FAQs

  • When was ALZpath founded?

    ALZpath was founded in 2020.

  • Where is ALZpath headquartered?

    ALZpath is headquartered in Carlsbad, CA.

  • What is the size of ALZpath?

    ALZpath has 11 total employees.

  • What industry is ALZpath in?

    ALZpath’s primary industry is Other Devices and Supplies.

  • Is ALZpath a private or public company?

    ALZpath is a Private company.

  • What is ALZpath’s current revenue?

    The current revenue for ALZpath is .

  • How much funding has ALZpath raised over time?

    ALZpath has raised $10.3M.

  • Who are ALZpath’s investors?

    StartUp Health, Alzheimers Drug Discovery Foundation, and Stead Impact Ventures and Foundation have invested in ALZpath.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process